These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 30753434)
1. Cross-species genetic screens to identify kinase targets for APP reduction in Alzheimer's disease. Huichalaf CH; Al-Ramahi I; Park KW; Grunke SD; Lu N; de Haro M; El-Zein K; Gallego-Flores T; Perez AM; Jung SY; Botas J; Zoghbi HY; Jankowsky JL Hum Mol Genet; 2019 Jun; 28(12):2014-2029. PubMed ID: 30753434 [TBL] [Abstract][Full Text] [Related]
2. Human Alzheimer's disease gene expression signatures and immune profile in APP mouse models: a discrete transcriptomic view of Aβ plaque pathology. Rothman SM; Tanis KQ; Gandhi P; Malkov V; Marcus J; Pearson M; Stevens R; Gilliland J; Ware C; Mahadomrongkul V; O'Loughlin E; Zeballos G; Smith R; Howell BJ; Klappenbach J; Kennedy M; Mirescu C J Neuroinflammation; 2018 Sep; 15(1):256. PubMed ID: 30189875 [TBL] [Abstract][Full Text] [Related]
3. Early intraneuronal amyloid triggers neuron-derived inflammatory signaling in APP transgenic rats and human brain. Welikovitch LA; Do Carmo S; Maglóczky Z; Malcolm JC; Lőke J; Klein WL; Freund T; Cuello AC Proc Natl Acad Sci U S A; 2020 Mar; 117(12):6844-6854. PubMed ID: 32144141 [TBL] [Abstract][Full Text] [Related]
4. Abeta conformational change is central to Alzheimer's disease. Holtzman DM Neurobiol Aging; 2002; 23(6):1085-8. PubMed ID: 12470806 [No Abstract] [Full Text] [Related]
5. Cerebrolysin decreases amyloid-beta production by regulating amyloid protein precursor maturation in a transgenic model of Alzheimer's disease. Rockenstein E; Torrance M; Mante M; Adame A; Paulino A; Rose JB; Crews L; Moessler H; Masliah E J Neurosci Res; 2006 May; 83(7):1252-61. PubMed ID: 16511867 [TBL] [Abstract][Full Text] [Related]
6. Regulation of Alzheimer beta-amyloid precursor trafficking and metabolism. Gandy S; Petanceska S Biochim Biophys Acta; 2000 Jul; 1502(1):44-52. PubMed ID: 10899430 [TBL] [Abstract][Full Text] [Related]
7. [Alzheimer disease: cellular and molecular aspects]. Octave JN Bull Mem Acad R Med Belg; 2005; 160(10-12):445-9; discussion 450-1. PubMed ID: 16768248 [TBL] [Abstract][Full Text] [Related]
8. Haplodeficiency of Cathepsin D does not affect cerebral amyloidosis and autophagy in APP/PS1 transgenic mice. Cheng S; Wani WY; Hottman DA; Jeong A; Cao D; LeBlanc KJ; Saftig P; Zhang J; Li L J Neurochem; 2017 Jul; 142(2):297-304. PubMed ID: 28429406 [TBL] [Abstract][Full Text] [Related]
9. Alzheimer's disease pathology is attenuated in a CD38-deficient mouse model. Blacher E; Dadali T; Bespalko A; Haupenthal VJ; Grimm MO; Hartmann T; Lund FE; Stein R; Levy A Ann Neurol; 2015 Jul; 78(1):88-103. PubMed ID: 25893674 [TBL] [Abstract][Full Text] [Related]
10. The effect of focal brain injury on beta-amyloid plaque deposition, inflammation and synapses in the APP/PS1 mouse model of Alzheimer's disease. Collins JM; King AE; Woodhouse A; Kirkcaldie MT; Vickers JC Exp Neurol; 2015 May; 267():219-29. PubMed ID: 25747037 [TBL] [Abstract][Full Text] [Related]
11. Vascular endothelial growth factor (VEGF) affects processing of amyloid precursor protein and beta-amyloidogenesis in brain slice cultures derived from transgenic Tg2576 mouse brain. Bürger S; Noack M; Kirazov LP; Kirazov EP; Naydenov CL; Kouznetsova E; Yafai Y; Schliebs R Int J Dev Neurosci; 2009 Oct; 27(6):517-23. PubMed ID: 19589380 [TBL] [Abstract][Full Text] [Related]
13. Berberine ameliorates β-amyloid pathology, gliosis, and cognitive impairment in an Alzheimer's disease transgenic mouse model. Durairajan SS; Liu LF; Lu JH; Chen LL; Yuan Q; Chung SK; Huang L; Li XS; Huang JD; Li M Neurobiol Aging; 2012 Dec; 33(12):2903-19. PubMed ID: 22459600 [TBL] [Abstract][Full Text] [Related]
14. Abeta as a bioflocculant: implications for the amyloid hypothesis of Alzheimer's disease. Robinson SR; Bishop GM Neurobiol Aging; 2002; 23(6):1051-72. PubMed ID: 12470802 [TBL] [Abstract][Full Text] [Related]
15. Dispersible amyloid β-protein oligomers, protofibrils, and fibrils represent diffusible but not soluble aggregates: their role in neurodegeneration in amyloid precursor protein (APP) transgenic mice. Rijal Upadhaya A; Capetillo-Zarate E; Kosterin I; Abramowski D; Kumar S; Yamaguchi H; Walter J; Fändrich M; Staufenbiel M; Thal DR Neurobiol Aging; 2012 Nov; 33(11):2641-60. PubMed ID: 22305478 [TBL] [Abstract][Full Text] [Related]
16. APP/Go protein Gβγ-complex signaling mediates Aβ degeneration and cognitive impairment in Alzheimer's disease models. Bignante EA; Ponce NE; Heredia F; Musso J; Krawczyk MC; Millán J; Pigino GF; Inestrosa NC; Boccia MM; Lorenzo A Neurobiol Aging; 2018 Apr; 64():44-57. PubMed ID: 29331876 [TBL] [Abstract][Full Text] [Related]
17. N-truncated Aβ Wirths O; Walter S; Kraus I; Klafki HW; Stazi M; Oberstein TJ; Ghiso J; Wiltfang J; Bayer TA; Weggen S Alzheimers Res Ther; 2017 Oct; 9(1):80. PubMed ID: 28978359 [TBL] [Abstract][Full Text] [Related]
18. Soluble Conformers of Aβ and Tau Alter Selective Proteins Governing Axonal Transport. Sherman MA; LaCroix M; Amar F; Larson ME; Forster C; Aguzzi A; Bennett DA; Ramsden M; Lesné SE J Neurosci; 2016 Sep; 36(37):9647-58. PubMed ID: 27629715 [TBL] [Abstract][Full Text] [Related]
19. Endogenous murine Aβ increases amyloid deposition in APP23 but not in APPPS1 transgenic mice. Mahler J; Morales-Corraliza J; Stolz J; Skodras A; Radde R; Duma CC; Eisele YS; Mazzella MJ; Wong H; Klunk WE; Nilsson KPR; Staufenbiel M; Mathews PM; Jucker M; Wegenast-Braun BM Neurobiol Aging; 2015 Jul; 36(7):2241-2247. PubMed ID: 25911278 [TBL] [Abstract][Full Text] [Related]
20. RAGE mediates Aβ accumulation in a mouse model of Alzheimer's disease via modulation of β- and γ-secretase activity. Fang F; Yu Q; Arancio O; Chen D; Gore SS; Yan SS; Yan SF Hum Mol Genet; 2018 Mar; 27(6):1002-1014. PubMed ID: 29329433 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]